BOL-148 (NYPRG-101)

About Ceruvia Lifesciences

Ceruvia Lifesciences is a private, clinical-stage biotech company pioneering an entirely new approach to psychiatric and neurological disorders by leveraging psychedelic drug development. The company's mission is to transform psychedelic research into cutting-edge medicine, focusing on non-hallucinogenic analogs to improve patient access and safety. With decades of experience in clinical drug development and commercialization, Ceruvia is advancing its lead candidate, BOL-148, through clinical research to establish safety and efficacy. The company is positioned at the forefront of the emerging neurotransformational medicine field, aiming to deliver meaningful relief to underserved patient communities.

Therapeutic Areas